Pelthos Therapeutics Revenue

Pelthos Therapeutics had revenue of $7.41M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $7.41M.

Revenue (ttm)

$7.41M

Revenue Growth

n/a

P/S Ratio

10.07

Revenue / Employee

$673,273

Employees

Market Cap

74.58M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	199.93K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Champions Oncology	58.42M
Coeptis Therapeutics Holdings	501.00K
Seres Therapeutics	351.00K
aTyr Pharma	190.00K
Impact BioMedical	25.00K
Fractyl Health	3.00K

Revenue Rankings

PTHS News

7 weeks ago - Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics - Business Wire
7 weeks ago - Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance - GlobeNewsWire
2 months ago - Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice - GlobeNewsWire
3 months ago - Pelthos Pharmaceuticals: Off To A Strong Start With Zelsuvmi, Continued Sales Growth Is Likely - Seeking Alpha
4 months ago - Pelthos Therapeutics Inc. (PTHS) Q3 2025 Earnings Call Transcript - Seeking Alpha
4 months ago - Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire
4 months ago - Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing - GlobeNewsWire
4 months ago - Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025 - GlobeNewsWire

More News